Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)

NIH RePORTER · NIH · R44 · $175,700 · view on reporter.nih.gov ↗

Abstract

Project Summary Volume overload (congestion) occurs in patients with heart failure (HF) and is the leading cause of hospitalization in the elderly worldwide. Unfortunately, clinical signs and symptoms; laboratory values; and existing diagnostic tools are unreliable in providing accurate assessment of volume status. Using a unique physiologic signal, Non-Invasive Venous waveform Analysis (NIVA), VoluMetrix has developed a proprietary device and algorithm designed for monitoring volume status in HF patients. Proof of concept data in humans and experimental animal models, demonstrate that NIVA provides a reliable indication of intravascular volume status (“pulmonary capillary wedge equivalent”). The work in this Phase IIB proposal will establish interface and usability studies to complete the process necessary for bridging the gap to commercialization.

Key facts

NIH application ID
11001052
Project number
3R44HL140669-05S1
Recipient
VOLUMETRIX, LLC
Principal Investigator
Kyle Mitchell Hocking
Activity code
R44
Funding institute
NIH
Fiscal year
2024
Award amount
$175,700
Award type
3
Project period
2018-08-21 → 2026-02-28